Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer

被引:0
|
作者
Zaheer Ali
Malin Vildevall
Gabriela Vazquez Rodriguez
Decky Tandiono
Ioannis Vamvakaris
Georgios Evangelou
Georgios Lolas
Konstantinos N. Syrigos
Alberto Villanueva
Michael Wick
Shenga Omar
Anna Erkstam
Julia Schueler
Anna Fahlgren
Lasse D. Jensen
机构
[1] BioReperia AB,Pathology Department
[2] Athens Chest Hospital “Sotiria”,3rd Department of Internal Medicine and Laboratory
[3] National & Kapodistrian University of Athens,Program Against Cancer Therapeutic Resistance (ProCURE)
[4] InCELLiA P.C,Division of Cardiovascular Medicine, Department of Medical and Health Sciences
[5] Catalan Institute of Oncology (ICO),Division of Cell Biology, Department of Biomedical and Clinical Sciences
[6] Bellvitge Institute for Biomedical Research (IDIBELL),undefined
[7] Oncobell Program,undefined
[8] L’Hospitalet del Llobregat,undefined
[9] Xenopat S.L.,undefined
[10] Parc Cientific de Barcelona (PCB),undefined
[11] XenoSTART,undefined
[12] Linköping University,undefined
[13] Charles River Laboratories,undefined
[14] Linköping University,undefined
关键词
Cancer; Zebrafish; Metastasis; Dissemination; Drug response; Xenograft; Lymph node; PDX; ZTX;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer
    Delebecq, TJ
    Porte, H
    Zerimech, F
    Copin, MC
    Gouyer, V
    Dacquembronne, E
    Balduyck, M
    Wurtz, A
    Huet, G
    CLINICAL CANCER RESEARCH, 2000, 6 (03) : 1086 - 1092
  • [42] Patient-derived xenograft models—the future of personalised cancer treatment
    Jenna Bhimani
    Katie Ball
    Justin Stebbing
    British Journal of Cancer, 2020, 122 : 601 - 602
  • [43] Patient-derived Xenograft (PDX) Models of EML4-ALK-driven Non-small Cell Lung Cancer: Development, Characterization and Clinical Correlation Analysis
    Wick, M.
    Thangasamy, A.
    Gamez, L.
    Brown, J.
    Chavez, R.
    Tolcher, A.
    Patnaik, A.
    Rodriguez, L.
    Mangold, G.
    Papadopoulos, K.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 20 - 20
  • [44] Generation of Non-Small Cell Lung Cancer Patient-Derived Xenografts to Study Intratumor Heterogeneity
    Kanaki, Zoi
    Voutsina, Alexandra
    Markou, Athina
    Pateras, Ioannis S.
    Potaris, Konstantinos
    Avgeris, Margaritis
    Makrythanasis, Periklis
    Athanasiadis, Emmanouil I.
    Vamvakaris, Ioannis
    Patsea, Eleni
    Vachlas, Konstantinos
    Lianidou, Evi
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    Klinakis, Apostolos
    CANCERS, 2021, 13 (10)
  • [45] Drug screening of non-small cell lung cancer patient-derived organoids in a microwell platform
    Luan, Qiyue
    Pulido, Ines
    Zhou, Jian
    Shimamura, Takeshi
    Papautsky, Ian
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Patient-derived Xenograft Models Reveal a Subset of Clinically Relevant Squamous Non-Small Cell Lung Cancers That Respond to Targeted EGFR Inhibition
    Cranston, A.
    Mckenzie, A.
    Mallinder, P.
    Reece-Smith, A.
    Lawrence, A.
    Fairley, D.
    Grabowska, A.
    Page, M.
    Kumari, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 19 - 19
  • [47] Surgical Treatment Outcomes of Patients with Non-Small Cell Lung Cancer and Lymph Node Metastases
    Shimizu, Yuki
    Koike, Terumoto
    Hasebe, Toshiki
    Nakamura, Masaya
    Goto, Tatsuya
    Toyabe, Shin-ichi
    Tsuchida, Masanori
    CANCERS, 2023, 15 (12)
  • [48] Lymph node metastasis-related genes discovered through patient-derived xenograft models
    Moon, Hyeong-Gon
    Moon, Hyun Hye
    Han, Wonshik
    Noh, Dong-Young
    CANCER RESEARCH, 2015, 75 (22)
  • [49] Establishment of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development
    Carlson, Patrick
    Ricono, Jill
    Mullins, Chelsea
    Broudy, Thomas
    Mirsaidi, Cyrus
    Nair, Praveen
    CANCER RESEARCH, 2014, 74 (19)
  • [50] Development of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development
    Mullins, Chelsea
    Ricono, Jill
    Nair, Praveen
    Mirsaidi, Cyrus
    Broudy, Thomas
    CANCER RESEARCH, 2015, 75